Sign in
Taking people in United StatesNo phase

Exercise and immune changes in slow-growing lymphoma or chronic leukemia patients

Studies how short-term and long-term exercise affects immune cells in people with CLL or NHL.

Key facts

Who runs it
Mayo Clinic
Where
Rochester and Scottsdale, United StatesSee the 2 sites
Trial code
Registry title
The Effects of Exercise on Immune Phenotype of Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients
Status
Recruiting
People taking part
70 people, planned
Started
12 Jun 2023
Expected to end
Apr 2028
Type of study
Interventional, 5 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Biospecimen Collection
  • Cardiopulmonary Exercise Testing
  • Dual X-ray Absorptiometry
  • Electronic Health Record Review
  • Exercise Intervention
  • Physical Examination
  • Questionnaire Administration
  • Spirometry
  • Physical Performance Testing
  • Best Practice
Record updated
9 April 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for English-speaking adults aged 18 to 80 with indolent non-Hodgkin lymphoma or chronic lymphocytic leukemia, to study how exercise affects the immune system. One part also includes healthy volunteers.

Age
18 to 80 years
Sex
All sexes can join.
Disease stage
Indolent non-Hodgkin lymphoma (confirmed by tissue examination); for one part of the study, chronic lymphocytic leukemia or small lymphocytic lymphoma only.
Earlier treatment
People now on treatment need at least 8 weeks of planned treatment left. People already treated must be at least 6 months past treatment and have none planned during the 12-week exercise period. People not yet treated must have no treatment scheduled during the trial.

Main reasons for not taking part

  • Healthy volunteers with known heart or lung disease such as heart disease, COPD or asthma
  • Healthy volunteers with a bone or muscle problem that limits exercise
  • Healthy volunteers who currently smoke or smoked in the past
  • People with uncontrolled high blood pressure or heart illness
  • People whose oncologist has not approved their taking part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • English speaking
  • Between the ages of 18-80
  • Histologically confirmed diagnosis of indolent non-Hodgkin lymphoma (NHL) will be required to participate in Aim 2 (CLL/SLL only), aim 3 and 4 (indolent NHL) and aim 5 (indolent NHL) of this study

Who cannot take part

  • Indolent NHL individuals receiving treatment must have least 8 weeks of planned treatment remaining and those who have already received treatment must be at least 6 months post and have no planned treatments during the 12-week intervention period to be eligible. Individuals that are participating prior to receiving treatment must not have any scheduled treatments during their participation. Individuals will be excluded if they have uncontrolled hypertension, cardiac illness, or are not approved by their oncologist to participate
  • Healthy subjects participating in Aim 1 will be excluded if they have known cardiovascular or pulmonary disease (e.g. heart disease, coronary artery disease, chronic obstructive pulmonary disease [COPD], asthma, etc.) an orthopedic or musculoskeletal limitation which would limit ability to exercise or are a current or former smoker

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

Where in United States

  • Mayo Clinic in RochesterRochester, United StatesContact: Clinical Trials Referral OfficeTaking people
  • Mayo Clinic in ArizonaScottsdale, United StatesContact: Clinical Trials Referral OfficeTaking people

About the trial

What the trial wants to find out

This clinical trial studies the effect of short-term (acute) and long-term (chronic) exercise on immune characteristics and function (phenotype) of patients with indolent non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment. Despite not needing therapy, these patients have significant immune dysfunction. This may lead to an increased risk of serious infections requiring hospitalization and an increased risk of secondary non-blood-based (hematologic) cancers. Increasing CLL patients overall physical fitness levels, through exercise during the observation stage, may provide a realistic approach means to increase survival, decrease treatment-related side effects, and improve immune function. Information learned from this study may help researchers determine whether a particular exercise regimen can be used to strengthen the immune system of indolent NHL and CLL patients, delay time to disease progression, assess the need for treatment, and assess infection rates.

The 5 groups in the trial

  • Aim 1 (vitals, spirometry, CPET, blood samples, DEXA)Treatment being tested

    Participants undergo measurement of height/weight and vital signs (blood pressure, temperature, heart and breathing rate), complete lung function testing (spirometry), undergo an exercise test (CPET), and undergo collection of blood samples on study. Participants may also undergo DEXA scan on study.

    Treatment: Biospecimen Collection, Cardiopulmonary Exercise Testing, Dual X-ray Absorptiometry, Electronic Health Record Review, Physical Examination, Questionnaire Administration, and Spirometry

  • Aim 2 (aerobic based training program, Aim 1 activities)Treatment being tested

    CLL patients complete aerobic based training program on study. Patients then complete all Aim 1 activities again after completion of aerobic based training program.

    Treatment: Biospecimen Collection, Cardiopulmonary Exercise Testing, Dual X-ray Absorptiometry, Electronic Health Record Review, Exercise Intervention, Physical Examination, Questionnaire Administration, and Spirometry

  • Aims 3-4 arm I (indolent NHL usual care)Existing treatment, for comparison

    Indolent NHL patients undergo measurement of height/weight and vital signs (blood pressure, temperature, heart and breathing rate), complete lung function testing (spirometry), undergo an exercise test (CPET), and undergo collection of blood samples on study. Participants may also undergo DEXA scan on study. Patients undergo muscular strength and functional endurance measurements of hand grip strength, upper body power via weighted chest pass, and leg strength with the timed chair stand test and 6MWT. Patients receive usual care on study.

    Treatment: Biospecimen Collection, Cardiopulmonary Exercise Testing, Dual X-ray Absorptiometry, Electronic Health Record Review, Physical Examination, Questionnaire Administration, Spirometry, Physical Performance Testing, and Best Practice

  • Aims 3-4 arm II (indolent NHL aerobic based training program)Existing treatment, for comparison

    Indolent NHL patients undergo measurement of height/weight and vital signs (blood pressure, temperature, heart and breathing rate), complete lung function testing (spirometry), undergo an exercise test (CPET), and undergo collection of blood samples on study. Participants may also undergo DEXA scan on study. Patients undergo muscular strength and functional endurance measurements of hand grip strength, upper body power via weighted chest pass, and leg strength with the timed chair stand test and 6MWT. Patients complete aerobic based training program on study. Patients then complete all baseline activities again after completion of aerobic based training program.

    Treatment: Biospecimen Collection, Cardiopulmonary Exercise Testing, Dual X-ray Absorptiometry, Electronic Health Record Review, Exercise Intervention, Physical Examination, Questionnaire Administration, Spirometry, Physical Performance Testing, and Best Practice

  • Aim 5 (repeat baseline activities)Treatment being tested

    All patients from Aims 3-4 will be invited to repeat Aims 3-4 baseline activities.

    Treatment: Biospecimen Collection, Cardiopulmonary Exercise Testing, Dual X-ray Absorptiometry, Electronic Health Record Review, Physical Examination, Questionnaire Administration, Spirometry, and Physical Performance Testing

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
The Effects of Acute and Chronic Exercise on the Immune Phenotype of Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients
Plain-language title
Exercise and immune changes in slow-growing lymphoma or chronic leukemia patientsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT05876923, who can take part
Record updated
9 April 2026